Humanity has suffered from infectious diseases throughout history and the psychological burden of prolonged stress and uncertainty. The coronavirus (SARS-CoV-2, COVID-19), is one such pandemic that produced long-term mental as well as physical sequelae. During 2020, the year of COVID, the stress and anxiety about this life-threatening virus led to a surge of health recommendations and clinical research into mindfulness meditation as a coping strategy. This short communication is an exploratory review of international clinical trials investigating mindfulness-based complementary therapies to reduce COVID induced stress-related or mental health conditions: clinical trial frequency by country as well as frequent populations investigated, specifically, healthcare and non-healthcare samples.